IMDRF publishes Guidance Draft on Clinical Studies with Software as a Medical Device
Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Register now for ECA's GMP Newsletter
The IMDRF (International Medical Devices Regulator Forum) is the successor organisation of the Global Harmonisation Task Force (GHTF). The objective of this organisation is to drive harmonisations within the medical device world. Australia, Brazil, Canada, China, Russia and Singapore are also members of this organisation beside the Triad (Europe, USA and Japan).
Recently, the IMDRF has published a guidance draft entitled "Software as a medical Device (SAMD): Clinical Evaulation". The topic "software" is being intensively discussed in the medical device area. On 46 pages in total, the IMDRF has laid down requirements for clinical evaluation with software. 6 pages at the end of the document are dedicated to examples of clinical evaluation concepts.
The objective of the document is to:
- describe relevant clinical evaluation methods which can be used for clinical evidence of software as a medical device.
- describe the required level of clinical evidence for different categories of software as a medical device.
- describe categories of software as medical device where independent review can be important or not important.
The FDA has adopted the IMDRF draft. Insofar, the document can also be found on the FDA website.
Related GMP News
21.01.2025FDA Warning Letter Statistics on Medical Devices in the past Fiscal Year
21.01.2025Artificial Intelligence in Medical Devices - Notified Bodies' Point of View
21.01.2025New FDA Guidance on Risk Analyses for Drugs, Biologics and Combination Products
08.10.2024EMA updates Question and Answer Document on Combination Products
08.10.2024Transparency Guidelines for Medical Devices with Artificial Intelligence
12.09.2024Notified Body Survey on Certificates & Applications under the Medical Devices/IVD Regulation